NASDAQ:RGLS   Regulus Therapeutics Inc.
RGLS .. We are in full phase two COVID-19. There are many aspects and many pharmaceutical companies that are trying to shine, especially in the research and experimentation of drugs of all kinds ... Let's add that a Master of Biotech finance like Steven Cohen buys 8.5% of shares (5.6 million shares). ..
Remember what happened to COCP when Cohen himself bought 2.5% of shares (2.5 million shares) and went from 0.8 to 2.5 in a week ... so beware so maximum long alert ..
I make you a super Christmas gift in advance. Happy trading everyone.
Commentaire:
PLS follower ..attention hereeeeeeee

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.